Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Lilly Teams Up With Lycia In Protein Degradation

Deal Watch 2021

Related Content

Hikma’s US Biosimilars Ambitions Begin With $150m Ustekinumab Deal

Aug 27 2021

Cipla Targets Global Respiratory Biosimilars With Kemwell JV

Aug 25 2021

Neuraxpharm and Panaxia Partner For Poland, After Germany And France

Aug 25 2021

MS Pharma Partners With Mabxience For Bevacizumab In MENA Region

Aug 31 2021

ASCO Offers Glimpse Of LAG-3 Inhibitors’ Potential Opportunities – And Limitations

Jun 07 2021

Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology

Aug 24 2021

Pfizer To Buy Trillium For $2.26bn In A Hematology Pipeline Play

Aug 23 2021

VectivBio Grabs Tail Of Comet Therapeutics In New Rare Disease Play

Aug 31 2021

Polyphor Pulled Out Of The Mire With EnBiotix Merger

Sep 02 2021

Sobi To Go Private In $8.1bn Buyout That Appreciates Growth Strategy

Sep 02 2021

Sunovion Plans September Launch For Parkinson’s 'Off' Episode Drug Kynmobi

May 24 2020

Related Companies

Eli Lilly and Company

Lycia Therapeutics, Inc.

Sumitomo Pharma Co., Ltd.

Sunovion Pharmaceuticals Inc.

Bial Pharmaceuticals

Precision BioSciences, Inc.

Tiziana Life Sciences plc

Voronoi, Inc.

Vertex Pharmaceuticals Incorporated

Arbor Biotechnologies

iBio, Inc.

RubrYc Therapeutics

Quantum BioPharma Ltd.

Lucid Psycheceuticals

Azurity Pharmaceuticals, Inc.

Arbor Pharmaceuticals, LLC

Abveris, Inc.

Abilita Bio Inc.

Eagle Pharmaceuticals, Inc.

Combioxin SA

Additional Topics

Deals M & A Business Strategies Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window